Baidu
map

血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2018 BSH指南：大出血管理中粘弹性止血试验的应用

2018-08-02 英国血液病学学会 Br J Haematol. 2018 Aug 2.

大出血粘弹性止血试验

2018年8月，英国血液病学学会(BSH)发布了大出血管理中粘弹性止血试验的应用指南，创伤患者大出血是导致发病和死亡的主要原因，本文主要针对大出血管理中粘弹性止血试验的应用提出指导建议。

中文标题：

2018 BSH指南：大出血管理中粘弹性止血试验的应用

英文标题：

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline.

发布机构：

英国血液病学学会

发布日期：

2018-08-02

简要介绍：

2018年8月，英国血液病学学会(BSH)发布了大出血管理中粘弹性止血试验的应用指南，创伤患者大出血是导致发病和死亡的主要原因，本文主要针对大出血管理中粘弹性止血试验的应用提出指导建议。 

拓展指南：与出血相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 BSH指南：大出血管理中粘弹性止血试验的应用)] GetToolGuiderByIdResponse(projectId=1, id=33e5a1c00162a5c8, title=2018 BSH指南：大出血管理中粘弹性止血试验的应用, enTitle=The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline., guiderFrom=Br J Haematol. 2018 Aug 2., authorId=null, author=, summary=2018年8月，英国血液病学学会(BSH)发布了大出血管理中粘弹性止血试验的应用指南，创伤患者大出血是导致发病和死亡的主要原因，本文主要针对大出血管理中粘弹性止血试验的应用提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Aug 02 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年8月，英国血液病学学会(BSH)发布了大出血管理中粘弹性止血试验的应用指南，创伤患者大出血是导致发病和死亡的主要原因，本文主要针对大出血管理中粘弹性止血试验的应用提出指导建议。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>出血</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=8152b1c0016000fe" title="抗栓药物治疗中颅内出血患者神经外科围手术期管理中国专家共识（2018版）" target=_blank>抗栓药物治疗中颅内出血患者神经外科围手术期管理中国专家共识（2018版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=5408d1c001589663" title="2018 ACOG委员会意见：经阴道超声检查评估绝经后阴道出血患者的子宫内膜（No.734）" target=_blank>2018 ACOG委员会意见：经阴道超声检查评估绝经后阴道出血患者的子宫内膜（No.734）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=b4e4f1c0015863b3" title="2018 亚太工作组共识：非静脉曲张性上消化道出血（更新版）" target=_blank>2018 亚太工作组共识：非静脉曲张性上消化道出血（更新版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=093991c0015560cb" title="神经外科围手术期出血防治专家共识（2018）" target=_blank>神经外科围手术期出血防治专家共识（2018）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=3fee31c00155584d" title="血凝酶在急性出血性疾病中应用的专家共识" target=_blank>血凝酶在急性出血性疾病中应用的专家共识</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%87%BA%E8%A1%80" target=_blank>有关出血更多指南</a></ul>, tagList=[TagDto(tagId=7923, tagName=大出血), TagDto(tagId=78861, tagName=粘弹性止血试验)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4392, appHits=49, showAppHits=0, pcHits=3047, showPcHits=1921, likes=113, shares=2, comments=3, approvalStatus=1, publishedTime=Tue Aug 07 21:44:57 CST 2018, publishedTimeString=2018-08-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 07 21:44:57 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 12:05:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 BSH指南：大出血管理中粘弹性止血试验的应用)])
2018 BSH指南：大出血管理中粘弹性止血试验的应用
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=337194, encodeId=8e2f33e19404, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Aug 07 23:24:17 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337189, encodeId=ee7933e189f4, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Aug 07 23:23:27 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337185, encodeId=ae5a33e185fe, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 07 23:19:15 CST 2018, time=2018-08-07, status=1, ipAttribution=)]
    2018-08-07 医者仁心5538

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=337194, encodeId=8e2f33e19404, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Aug 07 23:24:17 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337189, encodeId=ee7933e189f4, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Aug 07 23:23:27 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337185, encodeId=ae5a33e185fe, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 07 23:19:15 CST 2018, time=2018-08-07, status=1, ipAttribution=)]
    2018-08-07 惠映实验室

    学习了，谢谢分享。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=337194, encodeId=8e2f33e19404, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Aug 07 23:24:17 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337189, encodeId=ee7933e189f4, content=学习了，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Aug 07 23:23:27 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337185, encodeId=ae5a33e185fe, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 07 23:19:15 CST 2018, time=2018-08-07, status=1, ipAttribution=)]
    2018-08-07 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

Baidu
map
Baidu
map
Baidu
map